Paris, 22 June 2019
Prescrire's response to the public consultation from the European Commission (EC) underscores the importance of a specific regulatory framework, transparency, and rigorous and independent scientific assessment of the risks and benefits of artificial intelligence.
> Download Prescrire's response (pdf in French, 151 Ko)
©Prescrire June 2020
Share |
 |
 |